Description
In this issue:
REVIEWS
- Response criteria for MDS
- The immune landscape in myeloproliferative disorders
COVID-19
- Pro-inflammatory microparticles drive COVID-19 severity
ORIGINAL PAPERS
- TP53 mutations in DLBCL - a bad prognostic factor
- Haploidentical transplants - the donor's impact on outcome
- Obesity risks in childhood ALL
- ITP in the elderly
